← Open Payments lookup

RICHARD DREIZE: Open Payments

NPI 1114135001 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,591 in 63 payments from 8 companies in 2025. Trend: 2023 $648 · 2024 $1,582 · 2025 $1,591

Food & beverage: $1,591
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$299
E.R. Squibb & Sons, L.L.C.12$286
Otsuka America Pharmaceutical, Inc.12$280
Janssen Pharmaceuticals, Inc11$233
Alkermes, Inc.9$224
Luye Pharma (USA) Ltd.5$121
Neurocrine BioSciences, Inc.1$112
Indivior Inc.1$36

Products named: COBENFY, INVEGA SUSTENNA, ARISTADA, UZEDY, AUSTEDO XR, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, INGREZZA.

Industry payments across FL — which companies pay providers there.